REG - Croda International - Directorate Change

Croda InternationalAnnouncement

03/03/2025 16:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250303:nRSC1529Za&default-theme=true

RNS Number : 1529Z  Croda International PLC  03 March 2025

3 March 2025

 

Director retirement

 

Croda International Plc announces that Julie Kim will retire from the Board on
26 July 2025, having served four years as a non-executive director, in order
to focus on her executive commitments. Julie has recently been named as the
next CEO of Takeda Pharmaceutical.

 

Danuta Gray, Chair of Croda International Plc, commented:

 

"Julie Kim has made an excellent contribution and we wish her every success
for the future in the next stage of her executive career at Takeda
Pharmaceuticals."

 

 

For enquiries contact:

 

Investors:        David Bishop,
Croda                           +44 7823 874428

 

Media:             Charlie Armitstead, FTI Consulting     +44
7703 330269

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOADZGGFKFNGKZM